{"chebi_id":"95060","chebi_name":"dinaciclib","chebi_synonyms":["2-[(2S)-1-[3-ethyl-7-[(1-oxidopyridin-1-ium-3-yl)methylamino]pyrazolo[1,5-a]pyrimidin-5-yl]piperidin-2-yl]ethanol","MK7965","MK 7965","MK-7965","2-[(2S)-1-(3-ethyl-7-{[(1-oxidopyridin-3-yl)methyl]amino}pyrazolo[1,5-a]pyrimidin-5-yl)piperidin-2-yl]ethanol","SCH727965","SCH-727965","SCH 727965","(2S)-1-[3-ethyl-7-[[(1-oxido-3-pyridinyl)methyl]amino]pyrazolo[1,5-a]pyrimidin-5-yl]-2-piperidineethanol","dinaciclibum"],"diffprof_id_observed":["MTBLS6890_0001_00000001"],"diffprof_id_var_observed":[],"inchikey":"PIMQWRZWLQKKBJ-SFHVURJKSA-N","inn_name":"dinaciclib","iupac_name":"2-[(2<i>S</i>)-1-(3-ethyl-7-{[(1-oxidopyridin-3-yl)methyl]amino}pyrazolo[1,5-<em>a</em>]pyrimidin-5-yl)piperidin-2-yl]ethanol","num_study_observed":1,"reactome_ids":["R-HSA-1640170","R-HSA-453279","R-HSA-69231","R-HSA-69236","R-HSA-69278","R-HSA-9754119"],"reactome_names":["Cell Cycle","Mitotic G1 phase and G1/S transition","Cyclin D associated events in G1","G1 Phase","Cell Cycle, Mitotic","Drug-mediated inhibition of CDK4/CDK6 activity"],"study_id_observed":["MTBLS6890"],"study_id_var_observed":[],"synonym_name":"SCH-727965"}